Biomarin Pharmaceutical Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Hello, everyone. My name is Gena Wang, and I'm the midcap biotech Analyst at the Barclays. Welcome to our second virtual global healthcare conference. And first, I wish everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our events team and corporate access team, who made this virtual healthcare conference possible.
With that, I would like to introduce our next presenting company, BioMarin. With us, we have J.J. Bienaimé, Chairman and Chief Executive Officer; Hank Fuchs, President, Worldwide Research and Development; Brian Mueller, Chief Financial Officer.
With that, I will hand over to you, J.J. to give opening remarks.
Thank you, Gena, and thank you for all of us for joining us on today's call. So last week, we announced strong results in the fourth quarter and the full year 2020, demonstrating our continued operational
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
